Domača stranMEHCQ • OTCMKTS
add
Chrome Holding Co
3,20 $
Po zaprtju:(1,25 %)−0,040
3,16 $
Konec trgovanja: 17. okt., 16:02:12 GMT -4 · USD · OTCMKTS · Izjava
Prejšnji trg. dan.
3,16 $
Dnevni razpon
3,13 $ - 3,20 $
Letni razpon
0,47 $ - 6,21 $
Tržna kapitalizacija
88,13 mio. USD
Povprečni obseg
50,03 tis.
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
OTCMKTS
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
(USD) | jun. 2025info | Sprememba L/L |
---|---|---|
Prihodek | 25,42 mio. | −37,10 % |
Stroški poslovanja | 44,24 mio. | −43,21 % |
Čisti dohodek | −23,83 mio. | 65,67 % |
Čista dobičkovnost prihodkov | −93,74 | 45,41 % |
Earnings per share | — | — |
EBITDA | −28,49 mio. | 46,78 % |
Efektivna davčna stopnja | — | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
(USD) | jun. 2025info | Sprememba L/L |
---|---|---|
Denar. in kratkor. naložbe | 39,83 mio. | −76,57 % |
Skupna sredstva | 144,33 mio. | −60,79 % |
Skupne obveznosti | 187,19 mio. | −16,64 % |
Celoten lastniški kapital | −42,86 mio. | — |
Shares outstanding | 27,54 mio. | — |
Razmerje P/B | −2,03 | — |
Donosnost sredstev | −50,47 % | — |
Donosnost kapitala | 438,85 % | — |
Denarni tok
Neto sprememba denarnih sredstev
(USD) | jun. 2025info | Sprememba L/L |
---|---|---|
Čisti dohodek | −23,83 mio. | 65,67 % |
Denar iz dejavnosti | −28,99 mio. | 33,00 % |
Denar iz naložb | −1,03 mio. | 10,64 % |
Denar iz financiranja | 24,28 mio. | 269.711,11 % |
Neto sprememba denarnih sredstev | −5,74 mio. | 87,07 % |
Prost denarni tok | 22,86 mio. | 281,90 % |
Vizitka
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously confrontational relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Datum ustanovitve
apr. 2006
Sedež organizacije
Spletno mesto
Zaposleni
261